Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

BioXcel Therapeutics Inc Share Price

BTAI

NAQ

$1.58

+$0.04

(2.6%)

Industry: Biotechnology Sector: Health Care

BioXcel Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

BioXcel Therapeutics Inc Share Price Chart

BioXcel Therapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$33.68M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

184.36K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.20

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$1.17 L

$8.08 H

$1.58

About BioXcel Therapeutics Inc, Common Stock

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving film formulation of dexmedetomidine in Phase 3 trial for the treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer's disease, as well as opioid use disorder, alcohol use disorder with comorbid post-traumatic stress disorder, and acute stress disorder; and its immune-oncology candidate, BXCL701, which is an investigational oral innate immune activator that has completed Phase 1b/2a trial for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. In addition, the company engages in the development of BXCL502 for the treatment of stress-related neuropsychiatric symptoms in dementia and other stress-related disorders; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, which has the potential to address apathy and aggression in dementia. The company has collaborations with Columbia University, Yale University Medical School, and University of North Carolina for the development of BXCL501. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut. more

Industry: BiotechnologySector: Health Care

BioXcel Therapeutics Inc Stock Returns

Time Frame	BTAI	Sector	S&P500
1-Week Return	2.67%	-1.08%	-1.38%
1-Month Return	-24.88%	-0.47%	-1.81%
3-Month Return	-4.35%	2.13%	1.38%
6-Month Return	-72.5%	17.04%	5.68%
1-Year Return	-35.29%	6.56%	11.74%
3-Year Return	-99.71%	16.78%	65.15%
5-Year Return	-99.83%	34.34%	73.68%
10-Year Return	-99.13%	137.88%	260.03%

Time Frame	BTAI	Sector	S&P500
1-Week Return	295.09%	-43.23%	-51.55%
1-Month Return	-96.92%	-5.57%	-19.93%
3-Month Return	-16.50%	8.92%	5.72%
6-Month Return	-92.70%	37.58%	11.85%
1-Year Return	-35.29%	6.56%	11.74%
3-Year Return	-85.74%	5.31%	18.20%
5-Year Return	-72.07%	6.08%	11.67%
10-Year Return	-37.78%	9.05%	13.67%

BioXcel Therapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	24.30	-	375.00K	1.38M	2.27M	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":16.55,"profit":true},{"date":"2023-12-31","value":60.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	188.00K	297.00K	20.00K	1.26M	2.14M	[{"date":"2020-12-31","value":8.77,"profit":true},{"date":"2021-12-31","value":13.86,"profit":true},{"date":"2022-12-31","value":0.93,"profit":true},{"date":"2023-12-31","value":58.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	24.30	(297.00K)	355.00K	120.00K	123.00K	[{"date":"2020-12-31","value":0.01,"profit":true},{"date":"2021-12-31","value":-83.66,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":33.8,"profit":true},{"date":"2024-12-31","value":34.65,"profit":true}]
Gross Margin	100.00%	-	94.67%	8.70%	5.43%	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":94.67,"profit":true},{"date":"2023-12-31","value":8.7,"profit":true},{"date":"2024-12-31","value":5.43,"profit":true}]

Operating Expenses	82.30M	106.94M	160.00M	171.90M	67.37M	[{"date":"2020-12-31","value":47.87,"profit":true},{"date":"2021-12-31","value":62.21,"profit":true},{"date":"2022-12-31","value":93.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":39.19,"profit":true}]
Operating Income	(82.30M)	(106.94M)	(159.65M)	(171.78M)	(67.25M)	[{"date":"2020-12-31","value":-8229700000,"profit":false},{"date":"2021-12-31","value":-10693500000,"profit":false},{"date":"2022-12-31","value":-15964500000,"profit":false},{"date":"2023-12-31","value":-17178200000,"profit":false},{"date":"2024-12-31","value":-6724500000,"profit":false}]
Total Non-Operating Income/Expense	256.00K	8.00K	(11.80M)	(13.88M)	(4.88M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":3.13,"profit":true},{"date":"2022-12-31","value":-4608.2,"profit":false},{"date":"2023-12-31","value":-5422.27,"profit":false},{"date":"2024-12-31","value":-1906.64,"profit":false}]
Pre-Tax Income	(82.17M)	(106.93M)	(165.76M)	(179.05M)	(59.60M)	[{"date":"2020-12-31","value":-8216900000,"profit":false},{"date":"2021-12-31","value":-10693100000,"profit":false},{"date":"2022-12-31","value":-16575700000,"profit":false},{"date":"2023-12-31","value":-17905300000,"profit":false},{"date":"2024-12-31","value":-5959900000,"profit":false}]
Income Taxes	(161.00K)	(301.00K)	6.09M	150.10K	-	[{"date":"2020-12-31","value":-2.64,"profit":false},{"date":"2021-12-31","value":-4.94,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":2.46,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	(82.01M)	(106.63M)	(171.85M)	(179.20M)	-	[{"date":"2020-12-31","value":-8200800000,"profit":false},{"date":"2021-12-31","value":-10663000000,"profit":false},{"date":"2022-12-31","value":-17184900000,"profit":false},{"date":"2023-12-31","value":-17920310500,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(82.32M)	(106.93M)	(165.76M)	(211.60M)	(59.60M)	[{"date":"2020-12-31","value":-8232400000,"profit":false},{"date":"2021-12-31","value":-10693100000,"profit":false},{"date":"2022-12-31","value":-16575700000,"profit":false},{"date":"2023-12-31","value":-21160500000,"profit":false},{"date":"2024-12-31","value":-5959900000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(82.01M)	(106.63M)	(165.76M)	(179.05M)	(59.60M)	[{"date":"2020-12-31","value":-8200800000,"profit":false},{"date":"2021-12-31","value":-10663000000,"profit":false},{"date":"2022-12-31","value":-16575700000,"profit":false},{"date":"2023-12-31","value":-17905300000,"profit":false},{"date":"2024-12-31","value":-5959900000,"profit":false}]

EPS (Diluted)	(3.79)	(4.08)	(5.91)	(6.15)	(4.96)	[{"date":"2020-12-31","value":-379,"profit":false},{"date":"2021-12-31","value":-408,"profit":false},{"date":"2022-12-31","value":-591,"profit":false},{"date":"2023-12-31","value":-615,"profit":false},{"date":"2024-12-31","value":-496.27,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	-	-	268.00%	64.20%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":23.96,"profit":true}]
Cost of Revenue	-	57.98%	(93.27%)	6200.00%	70.08%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.94,"profit":true},{"date":"2022-12-31","value":-1.5,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.13,"profit":true}]
Gross Profit	-	(1222322.22%)	(219.53%)	(66.20%)	2.50%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-48892888.89,"profit":false},{"date":"2022-12-31","value":-8781.14,"profit":false},{"date":"2023-12-31","value":-2647.89,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	-	-	(90.81%)	(37.58%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Operating Expenses	-	29.94%	49.62%	7.44%	(60.81%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":60.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.99,"profit":true},{"date":"2024-12-31","value":-122.54,"profit":false}]
Operating Income	-	29.94%	49.29%	7.60%	(60.85%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":60.74,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":15.42,"profit":true},{"date":"2024-12-31","value":-123.46,"profit":false}]
Total Non-Operating Income/Expense	-	(96.88%)	(147562.50%)	17.67%	(64.84%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-548.39,"profit":false},{"date":"2022-12-31","value":-835314.21,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-367.02,"profit":false}]
Pre-Tax Income	-	30.14%	55.01%	8.02%	(66.71%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":54.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.58,"profit":true},{"date":"2024-12-31","value":-121.27,"profit":false}]
Income Taxes	-	86.96%	(2123.92%)	(97.54%)	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2442.51,"profit":false},{"date":"2023-12-31","value":-112.17,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	30.02%	61.16%	4.28%	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":49.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":7,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	29.89%	55.01%	27.66%	(71.83%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":54.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":50.28,"profit":true},{"date":"2024-12-31","value":-130.58,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	30.02%	55.45%	8.02%	(66.71%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":54.15,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.47,"profit":true},{"date":"2024-12-31","value":-120.31,"profit":false}]

EPS (Diluted)	-	7.65%	44.85%	4.06%	(19.31%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":17.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":9.05,"profit":true},{"date":"2024-12-31","value":-43.04,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	214.00K	366.00K	168.00K	120.00K	98.00K	[{"date":"2024-09-30","value":58.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":45.9,"profit":true},{"date":"2025-06-30","value":32.79,"profit":true},{"date":"2025-09-30","value":26.78,"profit":true}]
Cost of Revenue	1.17M	832.00K	14.00K	107.00K	86.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":71.11,"profit":true},{"date":"2025-03-31","value":1.2,"profit":true},{"date":"2025-06-30","value":9.15,"profit":true},{"date":"2025-09-30","value":7.35,"profit":true}]
Gross Profit	(956.00K)	(466.00K)	154.00K	13.00K	12.00K	[{"date":"2024-09-30","value":-620.78,"profit":false},{"date":"2024-12-31","value":-302.6,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":8.44,"profit":true},{"date":"2025-09-30","value":7.79,"profit":true}]
Gross Margin	(446.73%)	(127.32%)	91.67%	10.83%	12.24%	[{"date":"2024-09-30","value":-487.34,"profit":false},{"date":"2024-12-31","value":-138.9,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":11.82,"profit":true},{"date":"2025-09-30","value":13.36,"profit":true}]

Operating Expenses	14.34M	10.03M	10.25M	15.87M	13.94M	[{"date":"2024-09-30","value":90.37,"profit":true},{"date":"2024-12-31","value":63.2,"profit":true},{"date":"2025-03-31","value":64.63,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":87.87,"profit":true}]
Operating Income	(15.29M)	(10.49M)	(10.10M)	(15.85M)	(13.93M)	[{"date":"2024-09-30","value":-1529300000,"profit":false},{"date":"2024-12-31","value":-1049300000,"profit":false},{"date":"2025-03-31","value":-1009900000,"profit":false},{"date":"2025-06-30","value":-1585200000,"profit":false},{"date":"2025-09-30","value":-1392800000,"profit":false}]
Total Non-Operating Income/Expense	(1.53M)	(4.03M)	(869.00K)	(7.33M)	(21.12M)	[{"date":"2024-09-30","value":-153100000,"profit":false},{"date":"2024-12-31","value":-403000000,"profit":false},{"date":"2025-03-31","value":-86900000,"profit":false},{"date":"2025-06-30","value":-732700000,"profit":false},{"date":"2025-09-30","value":-2112000000,"profit":false}]
Pre-Tax Income	(13.65M)	(10.86M)	(7.25M)	(19.19M)	(30.91M)	[{"date":"2024-09-30","value":-1365000000,"profit":false},{"date":"2024-12-31","value":-1085900000,"profit":false},{"date":"2025-03-31","value":-725400000,"profit":false},{"date":"2025-06-30","value":-1918700000,"profit":false},{"date":"2025-09-30","value":-3091100000,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(13.65M)	(10.86M)	(7.25M)	(19.19M)	(30.91M)	[{"date":"2024-09-30","value":-1365000000,"profit":false},{"date":"2024-12-31","value":-1085900000,"profit":false},{"date":"2025-03-31","value":-725400000,"profit":false},{"date":"2025-06-30","value":-1918700000,"profit":false},{"date":"2025-09-30","value":-3091100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(13.65M)	(10.86M)	(7.25M)	(19.19M)	(30.91M)	[{"date":"2024-09-30","value":-1365000000,"profit":false},{"date":"2024-12-31","value":-1085900000,"profit":false},{"date":"2025-03-31","value":-725400000,"profit":false},{"date":"2025-06-30","value":-1918700000,"profit":false},{"date":"2025-09-30","value":-3091100000,"profit":false}]

EPS (Diluted)	(0.32)	(3.56)	(1.50)	(2.45)	(2.18)	[{"date":"2024-09-30","value":-32,"profit":false},{"date":"2024-12-31","value":-356.27,"profit":false},{"date":"2025-03-31","value":-150,"profit":false},{"date":"2025-06-30","value":-245,"profit":false},{"date":"2025-09-30","value":-218,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	71.03%	(54.10%)	(28.57%)	(18.33%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-76.16,"profit":false},{"date":"2025-06-30","value":-40.23,"profit":false},{"date":"2025-09-30","value":-25.81,"profit":false}]
Cost of Revenue	-	(28.89%)	(98.32%)	664.29%	(19.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-4.35,"profit":false},{"date":"2025-03-31","value":-14.8,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-2.95,"profit":false}]
Gross Profit	-	(51.26%)	(133.05%)	(91.56%)	(7.69%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Gross Margin	-	(71.50%)	(172.00%)	(88.18%)	13.03%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-548.73,"profit":false},{"date":"2025-03-31","value":-1320.02,"profit":false},{"date":"2025-06-30","value":-676.77,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	-	(30.06%)	2.25%	54.74%	(12.13%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-54.92,"profit":false},{"date":"2025-03-31","value":4.12,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-22.17,"profit":false}]
Operating Income	-	(31.39%)	(3.75%)	56.97%	(12.14%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-55.1,"profit":false},{"date":"2025-03-31","value":-6.59,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-21.31,"profit":false}]
Total Non-Operating Income/Expense	-	163.23%	(78.44%)	743.15%	188.25%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":21.96,"profit":true},{"date":"2025-03-31","value":-10.55,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":25.33,"profit":true}]
Pre-Tax Income	-	(20.45%)	(33.20%)	164.50%	61.10%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.43,"profit":false},{"date":"2025-03-31","value":-20.18,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":37.14,"profit":true}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	(20.45%)	(33.20%)	164.50%	61.10%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.43,"profit":false},{"date":"2025-03-31","value":-20.18,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":37.14,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(20.45%)	(33.20%)	164.50%	61.10%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.43,"profit":false},{"date":"2025-03-31","value":-20.18,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":37.14,"profit":true}]

EPS (Diluted)	-	1013.34%	(57.90%)	63.33%	(11.02%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-5.71,"profit":false},{"date":"2025-06-30","value":6.25,"profit":true},{"date":"2025-09-30","value":-1.09,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	217.06M	236.81M	202.87M	72.14M	37.39M	[{"date":"2020-12-31","value":91.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.67,"profit":true},{"date":"2023-12-31","value":30.46,"profit":true},{"date":"2024-12-31","value":15.79,"profit":true}]
Non-current Assets	2.87M	2.63M	2.98M	1.56M	944.00K	[{"date":"2020-12-31","value":96.18,"profit":true},{"date":"2021-12-31","value":88.01,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":52.23,"profit":true},{"date":"2024-12-31","value":31.62,"profit":true}]
Total Assets	219.94M	239.44M	205.85M	73.70M	38.34M	[{"date":"2020-12-31","value":91.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.97,"profit":true},{"date":"2023-12-31","value":30.78,"profit":true},{"date":"2024-12-31","value":16.01,"profit":true}]

Total Liabilities
Current Liabilities	11.84M	16.67M	32.90M	27.27M	22.23M	[{"date":"2020-12-31","value":36,"profit":true},{"date":"2021-12-31","value":50.66,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.88,"profit":true},{"date":"2024-12-31","value":67.58,"profit":true}]
Non-current Liabilities	1.40M	1.10M	96.18M	102.94M	109.21M	[{"date":"2020-12-31","value":1.28,"profit":true},{"date":"2021-12-31","value":1.01,"profit":true},{"date":"2022-12-31","value":88.07,"profit":true},{"date":"2023-12-31","value":94.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	13.24M	17.77M	129.08M	130.21M	131.44M	[{"date":"2020-12-31","value":10.07,"profit":true},{"date":"2021-12-31","value":13.52,"profit":true},{"date":"2022-12-31","value":98.2,"profit":true},{"date":"2023-12-31","value":99.06,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	24.00K	28.00K	28.00K	30.00K	49.00K	[{"date":"2020-12-31","value":48.98,"profit":true},{"date":"2021-12-31","value":57.14,"profit":true},{"date":"2022-12-31","value":57.14,"profit":true},{"date":"2023-12-31","value":61.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(138.86M)	(245.79M)	(411.55M)	(590.60M)	(650.20M)	[{"date":"2020-12-31","value":-13885700000,"profit":false},{"date":"2021-12-31","value":-24578800000,"profit":false},{"date":"2022-12-31","value":-41154500000,"profit":false},{"date":"2023-12-31","value":-59059800000,"profit":false},{"date":"2024-12-31","value":-65019700000,"profit":false}]
Other Stockholders' Equity	345.53M	467.43M	488.29M	534.06M	557.05M	[{"date":"2020-12-31","value":62.03,"profit":true},{"date":"2021-12-31","value":83.91,"profit":true},{"date":"2022-12-31","value":87.66,"profit":true},{"date":"2023-12-31","value":95.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	206.70M	221.67M	76.78M	(56.51M)	(93.10M)	[{"date":"2020-12-31","value":93.25,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.64,"profit":true},{"date":"2023-12-31","value":-25.49,"profit":false},{"date":"2024-12-31","value":-42,"profit":false}]

Total Liabilities & Shareholders Equity	219.94M	239.44M	205.85M	73.70M	38.34M	[{"date":"2020-12-31","value":91.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.97,"profit":true},{"date":"2023-12-31","value":30.78,"profit":true},{"date":"2024-12-31","value":16.01,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	9.10%	(14.33%)	(64.44%)	(48.17%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-157.56,"profit":false},{"date":"2023-12-31","value":-708.33,"profit":false},{"date":"2024-12-31","value":-529.46,"profit":false}]
Non-current Assets	-	(8.50%)	13.63%	(47.77%)	(39.45%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-62.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-350.55,"profit":false},{"date":"2024-12-31","value":-289.47,"profit":false}]
Total Assets	-	8.87%	(14.03%)	(64.20%)	(47.98%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-158.18,"profit":false},{"date":"2023-12-31","value":-723.95,"profit":false},{"date":"2024-12-31","value":-541.1,"profit":false}]

Total Liabilities
Current Liabilities	-	40.74%	97.38%	(17.12%)	(18.46%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":41.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.58,"profit":false},{"date":"2024-12-31","value":-18.96,"profit":false}]
Non-current Liabilities	-	(20.96%)	8604.07%	7.03%	6.08%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.24,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.08,"profit":true},{"date":"2024-12-31","value":0.07,"profit":true}]
Total Liabilities	-	34.23%	626.30%	0.88%	0.94%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":0.14,"profit":true},{"date":"2024-12-31","value":0.15,"profit":true}]

Total Shareholders' equity
Common Stock	-	16.67%	-	7.14%	63.33%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":26.32,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":11.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	-	77.01%	67.44%	43.51%	10.09%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":87.57,"profit":true},{"date":"2023-12-31","value":56.5,"profit":true},{"date":"2024-12-31","value":13.1,"profit":true}]
Other Stockholders' Equity	-	35.28%	4.46%	9.37%	4.30%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":12.65,"profit":true},{"date":"2023-12-31","value":26.57,"profit":true},{"date":"2024-12-31","value":12.2,"profit":true}]
Total Shareholders' equity	-	7.24%	(65.36%)	(173.60%)	64.76%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":11.18,"profit":true},{"date":"2022-12-31","value":-100.94,"profit":false},{"date":"2023-12-31","value":-268.08,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	8.87%	(14.03%)	(64.20%)	(47.98%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-158.18,"profit":false},{"date":"2023-12-31","value":-723.95,"profit":false},{"date":"2024-12-31","value":-541.1,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	47.79M	37.39M	37.78M	25.24M	44.40M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":78.24,"profit":true},{"date":"2025-03-31","value":79.04,"profit":true},{"date":"2025-06-30","value":52.82,"profit":true},{"date":"2025-09-30","value":92.91,"profit":true}]
Non-current Assets	1.10M	944.00K	789.00K	546.00K	389.00K	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":85.82,"profit":true},{"date":"2025-03-31","value":71.73,"profit":true},{"date":"2025-06-30","value":49.64,"profit":true},{"date":"2025-09-30","value":35.36,"profit":true}]
Total Assets	48.89M	38.34M	38.57M	25.79M	44.79M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":78.41,"profit":true},{"date":"2025-03-31","value":78.88,"profit":true},{"date":"2025-06-30","value":52.75,"profit":true},{"date":"2025-09-30","value":91.61,"profit":true}]

Total Liabilities
Current Liabilities	25.56M	22.23M	25.55M	33.38M	37.80M	[{"date":"2024-09-30","value":67.6,"profit":true},{"date":"2024-12-31","value":58.81,"profit":true},{"date":"2025-03-31","value":67.57,"profit":true},{"date":"2025-06-30","value":88.29,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	108.97M	109.21M	103.19M	100.08M	95.91M	[{"date":"2024-09-30","value":99.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":94.49,"profit":true},{"date":"2025-06-30","value":91.64,"profit":true},{"date":"2025-09-30","value":87.82,"profit":true}]
Total Liabilities	134.53M	131.44M	128.74M	133.46M	133.71M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":97.71,"profit":true},{"date":"2025-03-31","value":95.7,"profit":true},{"date":"2025-06-30","value":99.21,"profit":true},{"date":"2025-09-30","value":99.39,"profit":true}]

Total Shareholders' equity
Common Stock	42.00K	49.00K	59.00K	60.00K	73.00K	[{"date":"2024-09-30","value":57.53,"profit":true},{"date":"2024-12-31","value":67.12,"profit":true},{"date":"2025-03-31","value":80.82,"profit":true},{"date":"2025-06-30","value":82.19,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(639.34M)	(650.20M)	(657.45M)	(676.64M)	(707.55M)	[{"date":"2024-09-30","value":-63933800000,"profit":false},{"date":"2024-12-31","value":-65019700000,"profit":false},{"date":"2025-03-31","value":-65745100000,"profit":false},{"date":"2025-06-30","value":-67663800000,"profit":false},{"date":"2025-09-30","value":-70754900000,"profit":false}]
Other Stockholders' Equity	553.66M	557.05M	567.22M	568.91M	618.56M	[{"date":"2024-09-30","value":89.51,"profit":true},{"date":"2024-12-31","value":90.06,"profit":true},{"date":"2025-03-31","value":91.7,"profit":true},{"date":"2025-06-30","value":91.97,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(85.63M)	(93.10M)	(90.17M)	(107.67M)	(88.92M)	[{"date":"2024-09-30","value":-8563300000,"profit":false},{"date":"2024-12-31","value":-9310100000,"profit":false},{"date":"2025-03-31","value":-9017200000,"profit":false},{"date":"2025-06-30","value":-10766700000,"profit":false},{"date":"2025-09-30","value":-8891900000,"profit":false}]

Total Liabilities & Shareholders Equity	48.89M	38.34M	38.57M	25.79M	44.79M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":78.41,"profit":true},{"date":"2025-03-31","value":78.88,"profit":true},{"date":"2025-06-30","value":52.75,"profit":true},{"date":"2025-09-30","value":91.61,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(21.76%)	1.02%	(33.18%)	75.90%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-28.66,"profit":false},{"date":"2025-03-31","value":1.35,"profit":true},{"date":"2025-06-30","value":-43.71,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	-	(14.18%)	(16.42%)	(30.80%)	(28.75%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Assets	-	(21.59%)	0.59%	(33.13%)	73.69%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-29.29,"profit":false},{"date":"2025-03-31","value":0.81,"profit":true},{"date":"2025-06-30","value":-44.96,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(13.01%)	14.90%	30.65%	13.27%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-42.43,"profit":false},{"date":"2025-03-31","value":48.62,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":43.28,"profit":true}]
Non-current Liabilities	-	0.22%	(5.51%)	(3.02%)	(4.17%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-2521.38,"profit":false},{"date":"2025-06-30","value":-1380.75,"profit":false},{"date":"2025-09-30","value":-1909.08,"profit":false}]
Total Liabilities	-	(2.29%)	(2.05%)	3.66%	0.19%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-62.6,"profit":false},{"date":"2025-03-31","value":-56.07,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":5.21,"profit":true}]

Total Shareholders' equity
Common Stock	-	16.67%	20.41%	1.69%	21.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":76.92,"profit":true},{"date":"2025-03-31","value":94.19,"profit":true},{"date":"2025-06-30","value":7.82,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	-	1.70%	1.12%	2.92%	4.57%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":37.18,"profit":true},{"date":"2025-03-31","value":24.42,"profit":true},{"date":"2025-06-30","value":63.88,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	0.61%	1.83%	0.30%	8.73%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":7,"profit":true},{"date":"2025-03-31","value":20.93,"profit":true},{"date":"2025-06-30","value":3.42,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	-	8.72%	(3.15%)	19.40%	(17.41%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":44.95,"profit":true},{"date":"2025-03-31","value":-16.22,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-89.75,"profit":false}]

Total Liabilities & Shareholders Equity	-	(21.59%)	0.59%	(33.13%)	73.69%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-29.29,"profit":false},{"date":"2025-03-31","value":0.81,"profit":true},{"date":"2025-06-30","value":-44.96,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(66.35M)	(82.15M)	(135.34M)	(155.01M)	(72.03M)	[{"date":"2020-12-31","value":-6635000000,"profit":false},{"date":"2021-12-31","value":-8215300000,"profit":false},{"date":"2022-12-31","value":-13534100000,"profit":false},{"date":"2023-12-31","value":-15500600000,"profit":false},{"date":"2024-12-31","value":-7202700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(316.00K)	(445.00K)	(139.00K)	(20.00K)	-	[{"date":"2020-12-31","value":-31600000,"profit":false},{"date":"2021-12-31","value":-44500000,"profit":false},{"date":"2022-12-31","value":-13900000,"profit":false},{"date":"2023-12-31","value":-2000000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	247.36M	102.45M	96.24M	26.52M	36.66M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.42,"profit":true},{"date":"2022-12-31","value":38.91,"profit":true},{"date":"2023-12-31","value":10.72,"profit":true},{"date":"2024-12-31","value":14.82,"profit":true}]

Net Change in Cash	180.69M	19.85M	(39.24M)	(128.50M)	(35.37M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":10.98,"profit":true},{"date":"2022-12-31","value":-21.72,"profit":false},{"date":"2023-12-31","value":-71.12,"profit":false},{"date":"2024-12-31","value":-19.57,"profit":false}]

Free Cash Flow
Free Cash Flow	(66.67M)	(82.60M)	(135.48M)	(155.03M)	(72.03M)	[{"date":"2020-12-31","value":-6666600000,"profit":false},{"date":"2021-12-31","value":-8259800000,"profit":false},{"date":"2022-12-31","value":-13548000000,"profit":false},{"date":"2023-12-31","value":-15502600000,"profit":false},{"date":"2024-12-31","value":-7202700000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	23.82%	64.74%	14.53%	(53.53%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":36.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.44,"profit":true},{"date":"2024-12-31","value":-82.69,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	40.82%	(68.76%)	(85.61%)	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-168.45,"profit":false},{"date":"2023-12-31","value":-209.72,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(58.58%)	(6.06%)	(72.44%)	38.22%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-153.26,"profit":false},{"date":"2022-12-31","value":-15.86,"profit":false},{"date":"2023-12-31","value":-189.51,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	-	(89.02%)	(297.71%)	227.46%	(72.48%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-39.13,"profit":false},{"date":"2022-12-31","value":-130.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-31.86,"profit":false}]

Free Cash Flow
Free Cash Flow	-	23.90%	64.02%	14.43%	(53.54%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":37.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.53,"profit":true},{"date":"2024-12-31","value":-83.62,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(16.34M)	(14.81M)	(12.04M)	(12.57M)	(18.79M)	[{"date":"2024-09-30","value":-1633800000,"profit":false},{"date":"2024-12-31","value":-1480900000,"profit":false},{"date":"2025-03-31","value":-1204300000,"profit":false},{"date":"2025-06-30","value":-1257500000,"profit":false},{"date":"2025-09-30","value":-1878700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	454.00K	4.28M	13.20M	137.00K	37.53M	[{"date":"2024-09-30","value":1.21,"profit":true},{"date":"2024-12-31","value":11.39,"profit":true},{"date":"2025-03-31","value":35.18,"profit":true},{"date":"2025-06-30","value":0.37,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	(15.88M)	(10.53M)	1.16M	(12.44M)	18.75M	[{"date":"2024-09-30","value":-84.74,"profit":false},{"date":"2024-12-31","value":-56.19,"profit":false},{"date":"2025-03-31","value":6.18,"profit":true},{"date":"2025-06-30","value":-66.35,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(16.34M)	(14.81M)	(12.04M)	(12.57M)	(18.79M)	[{"date":"2024-09-30","value":-1633800000,"profit":false},{"date":"2024-12-31","value":-1480900000,"profit":false},{"date":"2025-03-31","value":-1204300000,"profit":false},{"date":"2025-06-30","value":-1257500000,"profit":false},{"date":"2025-09-30","value":-1878700000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(9.36%)	(18.68%)	4.42%	49.40%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-18.94,"profit":false},{"date":"2025-03-31","value":-37.81,"profit":false},{"date":"2025-06-30","value":8.94,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	841.85%	208.75%	(98.96%)	27295.62%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":3.08,"profit":true},{"date":"2025-03-31","value":0.76,"profit":true},{"date":"2025-06-30","value":-0.36,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Net Change in Cash	-	(33.69%)	(111.00%)	(1173.17%)	(250.71%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(9.36%)	(18.68%)	4.42%	49.40%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-18.94,"profit":false},{"date":"2025-03-31","value":-37.81,"profit":false},{"date":"2025-06-30","value":8.94,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

BioXcel Therapeutics Inc Ratios

BioXcel Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	BTAI
Cash Ratio	0.99
Current Ratio	1.17
Quick Ratio	1.16

BioXcel Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BTAI
ROA (LTM)	-67.31%
ROE (LTM)	-1766.94%

BioXcel Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BTAI
Debt Ratio Lower is generally better. Negative is bad.	2.99
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-1.99

BioXcel Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BTAI
Trailing PE	NM
Forward PE	NM
P/S (TTM)	44.79
P/B	3.97
Price/FCF	NM
EV/R	144.33
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is BioXcel Therapeutics Inc share price today?

BioXcel Therapeutics Inc (BTAI) share price today is $1.58

Can Indians buy BioXcel Therapeutics Inc shares?

Yes, Indians can buy shares of BioXcel Therapeutics Inc (BTAI) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BTAI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioXcel Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of BioXcel Therapeutics Inc (BTAI) via the Vested app. You can start investing in BioXcel Therapeutics Inc (BTAI) with a minimum investment of $1.

How to invest in BioXcel Therapeutics Inc shares from India?

You can invest in shares of BioXcel Therapeutics Inc (BTAI) via Vested in three simple steps:

Click on Sign Up or Invest in BTAI stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in BioXcel Therapeutics Inc shares

What is BioXcel Therapeutics Inc 52-week high and low stock price?

The 52-week high price of BioXcel Therapeutics Inc (BTAI) is $8.08. The 52-week low price of BioXcel Therapeutics Inc (BTAI) is $1.17.

What is BioXcel Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BioXcel Therapeutics Inc (BTAI) is

What is BioXcel Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioXcel Therapeutics Inc (BTAI) is 3.97

What is BioXcel Therapeutics Inc dividend yield?

The dividend yield of BioXcel Therapeutics Inc (BTAI) is 0.00%

What is the Market Cap of BioXcel Therapeutics Inc?

The market capitalization of BioXcel Therapeutics Inc (BTAI) is $33.68M

What is BioXcel Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of BioXcel Therapeutics Inc is BTAI

How Can Investors Use BioXcel Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of BioXcel Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether BioXcel Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from BioXcel Therapeutics Inc shares for Indian investors?

When investing in BioXcel Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the BioXcel Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare BioXcel Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of BioXcel Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that BioXcel Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

BioXcel Therapeutics Inc Share Price

BioXcel Therapeutics Inc Analyst Forecast

BioXcel Therapeutics Inc Share Price Chart

BioXcel Therapeutics Inc Key Stock Metrics

About BioXcel Therapeutics Inc, Common Stock

BioXcel Therapeutics Inc Stock Returns

BioXcel Therapeutics Inc Financials

BioXcel Therapeutics Inc Ratios

BioXcel Therapeutics Inc Liquidity Ratios

BioXcel Therapeutics Inc Asset Efficiency Ratios

BioXcel Therapeutics Inc Liability Ratios

BioXcel Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

BioXcel Therapeutics Inc Share Price

BioXcel Therapeutics Inc Analyst Forecast

BioXcel Therapeutics Inc Share Price Chart

BioXcel Therapeutics Inc Key Stock Metrics

About BioXcel Therapeutics Inc, Common Stock

BioXcel Therapeutics Inc Stock Returns

BioXcel Therapeutics Inc Financials

BioXcel Therapeutics Inc Ratios

BioXcel Therapeutics Inc Liquidity Ratios

BioXcel Therapeutics Inc Asset Efficiency Ratios

BioXcel Therapeutics Inc Liability Ratios

BioXcel Therapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²